Thomas J. Schuetz

Person

Framingham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of a α-galactosidase a deficiency
- Patent number 6,458,574
- Issue date Oct 1, 2002
- Transkaryotic Therapies, Inc.
- Richard F Selden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR ENHANCING THE KILLING OF TARGET CELLS...
- Publication number 20200109195
- Publication date Apr 9, 2020
- Compass Therapeutics LLC
- Jennifer Watkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR ENHANCING THE KILLING OF TARGET CELLS...
- Publication number 20200079867
- Publication date Mar 12, 2020
- Compass Therapeutics LLC
- Jennifer Watkins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS
- Publication number 20190031785
- Publication date Jan 31, 2019
- Compass Therapeutics LLC
- Thomas Joseph SCHUETZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS
- Publication number 20180318417
- Publication date Nov 8, 2018
- Compass Therapeutics LLC
- Thomas Joseph SCHUETZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of alpha-galactosidase a deficiency
- Publication number 20030113894
- Publication date Jun 19, 2003
- Transkaryotic Therapies, Inc., a Delaware corporation
- Richard F. Selden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of alpha-galactosidase a deficiency
- Publication number 20030077806
- Publication date Apr 24, 2003
- Transkaryotic Therapies, Inc., a Delaware corporation
- Richard F. Selden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas J. Schuetz

Person

Patents Grantslast 30 patents

Treatment of a &#x03B1;-galactosidase a deficiency

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR ENHANCING THE KILLING OF TARGET CELLS...

COMPOSITIONS AND METHODS FOR ENHANCING THE KILLING OF TARGET CELLS...

MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS

MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS

Treatment of alpha-galactosidase a deficiency

Treatment of alpha-galactosidase a deficiency

Treatment of a α-galactosidase a deficiency